Additional Patent Term Adjustment (PTA) may be available for some cases where an Information Disclosure Statement (IDS) was filed after a reply. Recently in Supernus Pharmaceuticals, Inc. v. Iancu..
The pharma industry and US FDA will reflect on a record breaking 2018 for drug approvals. The Center for Drug Evaluation and Research (CDER) approved 59 new drugs last year which is a significant..
We have published the second volume of our newsletter which gives an insight into the patent publication trends of the past year. The classification has been done based on countries, companies,..
MaxVal announces that all of our software products and services now support the USPTO’s upcoming Private PAIR changes.
In the December issue of the “Hot Topics in Tech” newsletter series, we take a glance at how mobile devices have transformed healthcare and became a crucial component in the medical field.
MaxVal’s E-Cigarettes report is now available through Patent LiveScape™, an analysis and reporting service that provides clients with interactive reports which extract actionable and predictive..
In this issue of the "Hot Topics in Tech" series, we provide a brief overview of the patent filing activity around implantable non-energy based devices for hypertension treatment and management...
This article provides a brief overview of the role of the autonomous nervous system in managing hypertension and describes various techniques related to neurostimulation. Patents revealing various..
MaxVal announces symphony® AI, the most advanced patent prosecution tool available on the market. It leverages the Salesforce Lightning architecture to integrate public and private data into a..
This issue covers cardiovascular diseases and discloses the technological categories and products related to the use of renal denervation approach for managing hypertension. It also talks about..
MaxVal announces the latest upgrade to its advanced, cloud-based IP management platform, symphony®.
Since its launch in 2016, symphony® has revolutionized IP management through its innovative use..
In this issue, we have covered a couple of hot topics that are currently trending in the biotech and blockchain technology industries. We have highlighted Illumina’s Q2 results and provided some..
In this issue, we have covered a couple of hot topics that are currently trending in the biotech and cloud-tech industries. We have talked about the FDA's approval of tisagenlecleucel (KYMRIAH,..
Although CRISPR was known to have an important role in bacterial immunity for over a decade, it is only in the last 5 years that it has garnered interest as a gene editing tool. Increasing..
The article presents a base editing approach to expand the scope and efficiency of CRISPR mediated genome editing.
The article addresses Medtronic’s recent FDA approval of the Guardian™ Connect Continuous Glucose Monitoring (CGM) system. A brief overview of all the clinical studies related to CGM has been..